| Product Name | MF | CAS | Details |
|---|
| Fulzerasib（IBI351 ; GFH925） | C32H30ClFN6O4 | 2641747-54-6 | Details |
| C5H11NO3 | 6152-89-2 | Details |
| 1H-BenziMidazole, 6-(2-chloro-5- fluoro-4-pyr iMidinyl)-4-fluoro-2- Methyl-1-(1-Methylethyl)- | C15H13ClF2N4 | 1231930-42-9 | Details |
| BAPTA-AM | C34H40N2O18 | 126150-97-8 | Details |
| DC0-NH2 | C31H24ClN5O3 | 615538-51-7 | Details |
| 9H-Thioxanthene-2-acetic acid | C15H10O3S | 27011-96-7 | Details |
| C8H15NO4 | 2157013-33-5 | Details |
| FostaMatinib DisodiuM Hexahydrate | C23H24FN6Na2O9P | 914295-16-2 | Details |
| C15H19NO7 | 1031702-80-3 | Details |
| C16H18O8 | 6160-78-7 | Details |
| C13H17NO7 | 175281-76-2 | Details |
| IPTG | C9H18O5S | 367-93-1 | Details |
| B-[2-(9H-Carbazol-9-yl)phenyl]boronic acid | C18H14BNO2 | 1189047-28-6 | Details |
| Oxatomide | C27H30N4O | 60607-34-3 | Details |
| XL388 | C23H22FN3O4S | 1251156-08-7 | Details |
| AZD-4205 | C25H31N9O2 | 2091134-68-6 | Details |
| C16H16O4 | 56410-30-1 | Details |
| 2,3-Dimethoxy-1,3-butadiene | C6H10O2 | 3588-31-6 | Details |
| 2-AMino-4-fluoropyridine | C5H5FN2 | 944401-77-8 | Details |
| C3H7O7P | 23295-92-3 | Details |
| C8H6N2O4 | 4415-88-7 | Details |
| C7H4BrNO | 92404-58-5 | Details |
| Luseogliflozin | C23H30O6S | 898537-18-3 | Details |
| C12H8N4O6S | 118876-58-7 | Details |
| C6H10N4O2 | 5440-00-6 | Details |
| 4-Hydroxy-2-methylpyridine | C6H7NO | 18615-86-6 | Details |
| 3-((3R,4S)-4-Methyl-3-(Methyl(7H- pyrrolo[2,3-d]pyr iMidin-4- yl)aMino)piperidin-1-yl)-3- oxopropanenitrile | C16H20N6O | 1092578-46-5 | Details |
| Deferasirox Fe3+ chelate | C21H12FeN3O4 | 554435-83-5 | Details |
| IFN alpha-IFNAR-IN-1 hydrochloride | C18H18ClNS | 2070014-98-9 | Details |
| (S)-3-(Pyrrolidin-2-yl)pyridine | C9H12N2 | 494-97-3 | Details |
| C15H10O5 | 485-63-2 | Details |
| Ellipticine | C17H14N2 | 519-23-3 | Details |
| C10H16N4Na2O6 | 918149-29-8 | Details |
| C10H12O2 | 6138-88-1 | Details |
| C17H19FN4O2S | 860352-01-8 | Details |
| PF-562271 | C21H20F3N7O3S | 717907-75-0 | Details |
| 5-((4-Ethylpiperazin-1- yl)methyl)pyr idin-2-amine | C12H20N4 | 1180132-17-5 | Details |
| N-BUTYLDEOXYNOJIRIMYCIN, HYDROCHLORIDE | C10H22ClNO4 | 210110-90-0 | Details |
| N-[[4-(2,2-dicyano-1-methoxy- vinyl)phenyl]methyl]-5-fluoro-2- methoxy-benzamide | C20H16FN3O3 | 2764851-04-7 | Details |
| C27H32O13 | 53861-35-1 | Details |
| GI 254023X | C21H33N3O4 | 260264-93-5 | Details |
| C43H45ClN8O5 | 2632305-17-8 | Details |
| C47H45FN6O17 | 2763252-25-9 | Details |
| ABT-494 intermediate | C15H19NO4 | 1428243-24-6 | Details |
| Succinyl phosphonate trisodium salt | C4H8NaO6P | 864167-45-3 | Details |
| C13H15NO7 | 188891-18-1 | Details |
| Fagomine | C6H13NO3 | 53185-12-9 | Details |
| C7H6F3NO2S | 133046-46-5 | Details |
| Palovarotene | C27H30N2O2 | 410528-02-8 | Details |
| Benzamil HCl | C13H15Cl2N7O | 161804-20-2 | Details |
| 3-amino-N-(2-bromo-4,6- difluorophenyl)-6,7-dihydro-5H- cy clopenta[b]thieno[3,2-e]pyr idine- 2-carboxamide | C17H12BrF2N3OS | 497061-48-0 | Details |
| ONO-AE3-208 | C24H21FN2O3 | 402473-54-5 | Details |
| 5α-Cholestan-3β-ol | C27H48O | 80-97-7 | Details |
| 9-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole | C24H24BNO2 | 1357634-60-6 | Details |
| Phosphoramidon Disodium | C23H35N3NaO10P | 164204-38-0 | Details |
| TMRE | C26H27ClN2O7 | 115532-52-0 | Details |
| C6H5NO4 | 55750-48-6 | Details |
| 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[(methoxymethylamino)carbonyl]-, phenylmethyl ester, (3S,4R)- | C17H24N2O4 | 2411540-28-6 | Details |
| C13H8Cl2F2N2O3 | 943832-81-3 | Details |
| GSK-7975A | C18H12F5N3O2 | 1253186-56-9 | Details |
| C8H20NO6P | 563-24-6 | Details |
| Talnetant (SB 223412) | C25H22N2O2 | 174636-32-9 | Details |
| Diacetato[(S)-(-)-5,5'-bis(diphenylphosphino)-4,4'-bi-1,3-benzodioxole]ruthenium(II) | C38H28O4P2.C4H6O4Ru | 373650-12-5 | Details |
| 952518-97-1 | Details |
| IDE397 (GSK-4362676) | Details |
| RXC004 | C21H16F3N7O | 1900754-56-4 | Details |
| 1-Pyrrolidinecarboxylic acid, 3-(2-bromoacetyl)-4-ethyl-, phenylmethyl ester, (3R,4R)-rel- | C16H20BrNO3 | 2304514-60-9 | Details |
| N1-Caffeoylspermidine | C16H25N3O3 | 69563-41-3 | Details |
| C16H23NO2 | 163877-11-0 | Details |
| δ-D-Mannonolactone | C6H10O6 | 32746-79-5 | Details |
| AU-24118 | Details |
| 3-Chloro-1-[tris(1-methylethyl)silyl]-1H-pyrrole | C13H24ClNSi | 130408-83-2 | Details |
| CVN293 | C14H10FN7O | 2815296-08-1 | Details |
| C13H11F3N2O | 191279-34-2 | Details |
| Tris(dibenzoylMethan | C45H33ErO6.C12H8N2 | 61918-86-3 | Details |
| C20H21F6N7O2 | 2715120-86-6 | Details |
| IFN alpha-IFNAR-IN-1 | C18H17NS | 844882-93-5 | Details |
| PDS-0330 | C25H17N3O2S | 2904682-19-3 | Details |
| Pentanedioic acid | C9H15BrO4 | 2138520-49-5 | Details |
| BGTC | C36H66N8O2 | 182056-06-0 | Details |
| C4H4N2O | 51953-13-0 | Details |
| 2-bromo-5-methoxy-5-oxopentanoic acid | C6H9BrO4 | 95352-12-8 | Details |
| C5H11NO2S2 | 15579-00-7 | Details |
| (S)-2,3-Bis(benzyloxy)propan-1-ol | C17H20O3 | 20196-71-8 | Details |
| Cp2-SO4 | Details |
| C6H14NO8P | 26289-09-8 | Details |
| 1,5,6-trihydroxy-2-methyl-anthracene-9,10-dione | C15H10O5 | 478-29-5 | Details |
| C27H32O13 | 53823-09-9 | Details |
| Details |
| 8-Azaadenosine | 10229-44-2 | Details |
| IK-930 | Details |
| C11H16F3NO4 | 2242748-36-1 | Details |
| Ledipasvir (D-tartrate | C53H60F2N8O12 | 1502654-87-6 | Details |
| TPX-0131 | C21H20F3N5O3 | 2648641-36-3 | Details |
| 4-amino-1-[4-(hydroxymethyl)-7,7-dimethyl-3,6,8-trioxabicyclo[3.3.0]oct-2-yl]-1,3,5-triazin-2-one | C11H16N4O5 | 65370-90-3 | Details |
| ML-7 | C15H18ClIN2O2S | 110448-33-4 | Details |
| 2,3,6,7-Naphthalenetetrol | C10H8O4 | 131142-80-8 | Details |
| 24080790-02-1 | Details |
| C13H22N2O7 | 88270-91-1 | Details |
| SOQUELITINIB | C25H30N4O4S2 | 2226636-04-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 | ||||